Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B. - Wikidata - awgldk - TriplyDB

Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B.

Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B.

http://www.wikidata.org/entity/Q37123896

about

Role of the microbiome in non-gastrointestinal cancers Mouse models of hepatitis B virus infection comprising host-virus immunologic interactions Hepatitis B Management in the Pregnant Patient: An Update Hepatitis B: progress in understanding chronicity, the innate immune response, and cccDNA protection Type-I interferons suppress microglial production of the lymphoid chemokine, CXCL13.Immune therapeutic strategies in chronic hepatitis B virus infection: virus or inflammation control?STING agonists induce an innate antiviral immune response against hepatitis B virus.Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota Trained immunity in newborn infants of HBV-infected mothers Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide Process of hepatic metastasis from pancreatic cancer: biology with clinical significance.Role of interleukin-21 in HBV infection: friend or foe?Phenotype and function of CXCR5+CD45RA-CD4+ T cells were altered in HBV-related hepatocellular carcinoma and elevated serum CXCL13 predicted better prognosis.Maternal-Derived Hepatitis B Virus e Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence after Vertical Transmission.Genetic variant in CXCL13 gene is associated with susceptibility to intrauterine infection of hepatitis B virus.A Novel Rabies Vaccine Expressing CXCL13 Enhances Humoral Immunity by Recruiting both T Follicular Helper and Germinal Center B Cells Elevated Expression of Chemokine CXCL13 in Chronic Hepatitis B Patients Links to Immune Control during Antiviral Therapy.Interleukin-21: a double-edged sword with therapeutic potential.The immune tolerant phase of chronic HBV infection: new perspectives on an old concept Age-Dependent Immune Events during HBV Infection from Birth to Adulthood: An Alternative Interpretation.Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response?Immune Response in Hepatitis B Virus Infection.Host-virus interactions in hepatitis B virus infection.Treatment of chronic hepatitis B with pattern recognition receptor agonists: Current status and potential for a cure Therapeutic strategies for a functional cure of chronic hepatitis B virus infection.Activation of Stimulator of Interferon Genes in Hepatocytes Suppresses the Replication of Hepatitis B Virus.Tolerance and immunity to pathogens in early life: insights from HBV infection.Liver capsule: Age-influenced hepatic immune priming determines HBV infection fate: Implications from mouse to man.Mechanisms of Hepatitis B Virus Persistence.Feedback regulation of IFN-α/β signaling by Axl receptor tyrosine kinase modulates HBV immunity.Hepatitis B virus persistence in mice reveals IL-21 and IL-33 as regulators of viral clearance.Modulators of innate immunity as novel therapeutics for treatment of chronic hepatitis B.An OX40/OX40L interaction directs successful immunity to hepatitis B virus.

P2860

Q26747710-0D2D2C5A-A11E-4323-90E7-885C7431B5E4 Q27002598-CCF6473E-997B-4E6F-8CF8-F52AD15BFD3A Q28066219-ABA0E268-303E-4194-8685-7A938B661AFB Q28069273-B2B55032-A30F-43C0-86CF-8FE14C620936 Q34083294-57692F30-93A7-4E4E-BDFC-E1BC6C2D6F00 Q35075107-F87AFE6E-D74E-4065-8232-BF7652BE2FAB Q35105855-C5983904-DC00-43B4-9F4C-C078560FEF45 Q35129064-C26806C6-D9CB-4ECF-ADAB-998B51DD3DFA Q35311846-0C999CDB-AC31-4C44-B464-93E32244D9C2 Q35526264-FD3AD220-A78A-4DE4-8678-2FECD66EA406 Q35739397-3ABFA743-9E01-4BDE-BF43-4E6E5B9E9326 Q36302671-AC20633F-BC0D-42F7-A31B-0E9A897D2221 Q36688945-5F9B758C-97A3-488E-A272-BCE7ADCBAC8C Q36913522-2E8E1F8D-A32D-4211-AB7D-F22B95FCA393 Q36925448-B2798BE1-E7A0-4396-B04E-F08964262FDF Q37593174-B110B791-2494-44CF-B6D1-0B45326BC921 Q37716774-D8D9A8BA-2AB3-452B-8ECB-486B88D380F5 Q38206058-D55EADFC-0B76-4468-8A94-C3B822E078C1 Q38245181-417DBFB4-F056-4B0C-BE4A-A8C02915C7D2 Q38258081-224CBBB4-98EA-4F81-9CAC-42E422D364DF Q38289729-4A016EF9-BA0C-4D62-8C63-2A0A099BA394 Q38541811-0C560B3C-13D4-4E2F-96A3-CBEEA32FC7A1 Q38549354-671E7E65-EF87-49FF-9D41-2A73764A176D Q38553065-5F77255F-271B-4C20-8559-5430A4508B2F Q38636988-3AE78D33-B129-42DF-9327-5C617DA89A85 Q38697029-4A09CA2B-212C-4D9D-8C56-291AE00C896F Q39419957-45B0E48F-0964-4BE0-B398-62015A66A96D Q39460683-82E80173-E064-401F-B65E-02325CE08986 Q40077350-BC239C96-D8B7-4373-A5D5-7D50D2FB0873 Q41372536-6E20525C-0FCE-49D1-BF95-7382C8070706 Q47117235-C2F66A4E-B06F-4B2A-94AE-D3100486447C Q49997050-8E1FFFD3-18FF-4B80-B479-039F641D9180 Q52644026-36A062F0-4657-4659-A3D0-B96961A9B6A3

P2860

Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B.

http://www.wikidata.org/entity/Q37123896

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B.

@en

Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B.

@nl

type

label

Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B.

@en

Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B.

@nl

prefLabel

Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B.

@en

Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B.

@nl

P1433

Q37123896-99D61F20-2C8F-46DC-8BC7-439041CB8010

P1476

Q37123896-8C03BF9D-6034-4C3F-BE5E-01FB8A34CBA3

P2093

Q37123896-0E145BC2-FB23-4E48-9646-8D72733E56B4

Q37123896-160AA094-D9BF-4105-B4DF-2E1E0645944D

Q37123896-1848B551-3B94-4529-A589-AE344E02889B

Q37123896-6AA9365B-9EEC-493F-8F46-25D89A397500

Q37123896-995D21F5-CFAC-4805-93C7-83D7FAEB862A

Q37123896-A0C1ECE0-3D3E-42E5-A66D-8CE70117BE18

Q37123896-B99E48CD-BA01-4165-AE00-00A15FA85673

Q37123896-BAAE3910-B6FB-4274-9833-BDF95362B619

Q37123896-D690DEA4-AA84-48B6-BAFC-2DC785417CC5

Q37123896-DB66136E-400A-4C4C-9C01-8BE0B6A1C65D

P2860

Q37123896-0769FB19-529B-4355-942B-E7375055B992

Q37123896-169BBE00-C5EF-494B-BBE8-FC320B8B7146

Q37123896-193984EB-7F56-41AC-8D0C-25F147FD6588

Q37123896-1C093D00-0D12-4A60-A8F0-7D6E36D05DDD

Q37123896-1ED3C45C-3634-44A3-9FFB-C1698EB40A2D

Q37123896-224A08A8-9437-4E3F-BD90-21B3DFA1B842

Q37123896-231D86C1-3556-4FFF-A8D4-C1B0FFE959B3

Q37123896-2FC8B467-5AF6-4175-9C91-C6345D9E5752

Q37123896-3013867C-810D-495C-885B-E183F6D185E0

Q37123896-327FAF84-6986-45FC-A5B3-A8D4A9933CC8

P304

Q37123896-5E288A89-0497-4641-AEC9-8A783CC7E371

P31

Q37123896-AC0F8518-B541-40C6-A087-583CF0C9A949

P356

Q37123896-6078479B-42A8-4020-915D-EEC581BAA535

P407

Q37123896-9D9F82B8-7899-4D11-9E2C-E55E0B0C0D37

P433

Q37123896-F8E0BD7F-BAE0-4C29-9AC4-F369E14F3E0F

P478

Q37123896-2346B8C9-A267-42E3-95E7-C5647CF48542

P50

Q37123896-010E1E64-B57D-4541-8F3B-0EEAB701CA49

Q37123896-1016689B-B6C0-486C-8CF2-D205053C32E8

Q37123896-9484FDE0-AF89-4E62-97B6-AB39A1598340

Q37123896-EA97D2FD-E990-40B9-96F6-C01141B10F2A

P577

Q37123896-9EC5E2D2-292D-4EEF-89E5-C778DE401995

P698

Q37123896-2ED4951A-857D-4BC1-A839-E6C583FBF202

P932

Q37123896-D3E6DE6F-D05B-4624-87F2-7DF0F5908B79

P356

P1433

Journal of Clinical Investigation

P1476

Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B.

@en

P2093

Adil E Wakil

http://www.w3.org/2001/XMLSchema#string

Amanda Goodsell

http://www.w3.org/2001/XMLSchema#string

Anuj Gaggar

http://www.w3.org/2001/XMLSchema#string

Jason G Cyster

http://www.w3.org/2001/XMLSchema#string

Jean Publicover

http://www.w3.org/2001/XMLSchema#string

Jody L Baron

http://www.w3.org/2001/XMLSchema#string

Marion Peters

http://www.w3.org/2001/XMLSchema#string

Philip Rosenthal

http://www.w3.org/2001/XMLSchema#string

R Lee Reinhardt

http://www.w3.org/2001/XMLSchema#string

Stephen Nishimura

http://www.w3.org/2001/XMLSchema#string

P2860

Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis

Hepatitis B: the virus and disease

Kupffer cells hasten resolution of liver immunopathology in mouse models of viral hepatitis

A chemokine-driven positive feedback loop organizes lymphoid follicles

Local control of the immune response in the liver

CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity

A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen

RAG-1-deficient mice have no mature B and T lymphocytes

Hepatitis B virus infection--natural history and clinical consequences

Neo-lymphoid aggregates in the adult liver can initiate potent cell-mediated immunity.

P304

3728-3739

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI68182

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P50

Marcus O. Muench

Christine M Van Horn

Nico van Rooijen

P577

2013-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23925290

http://www.w3.org/2001/XMLSchema#string

P932

3754256

http://www.w3.org/2001/XMLSchema#string